Skip Navigation



NDT Advance Access published online on March 29, 2005

Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfh774
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
20/6/1172    most recent
gfh774v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Näsström, B.
Right arrow Articles by Olivecrona, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Näsström, B.
Right arrow Articles by Olivecrona, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2005]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org
Received November 8, 2004
Accepted February 11, 2005


Original Articles

A single bolus of a low molecular weight heparin to patients on haemodialysis depletes lipoprotein lipase stores and retards triglyceride clearing

Birgit Näsström 1, Bernd Stegmayr 1, Jitendra Gupta 2, Gunilla Olivecrona 2, and Thomas Olivecrona 2*

1 Department of Public Health and Clinical Medicine, Nephrology, Umeå University, Umeå, Sweden
2 Department of Medical Biosciences, Physiological Chemistry, Umeå University, Umeå, Sweden

* To whom correspondence should be addressed.
Thomas Olivecrona, E-mail: thomas.olivecrona{at}medbio.umu.se



  Abstract

Background. Low molecular weight heparins (LMWH) are increasingly used during haemodialysis (HD) to prevent clotting in the extracorporeal devices. It has been suggested that LMWH release endothelial-bound lipoprotein lipase (LPL) less efficiently than unfractionated heparin (UFH) does and thereby cause less disturbance of lipid metabolism. Evidence from in vitro studies and from animal experiments indicate, however, that both types of heparin preparations have the same ability to release endothelial LPL, but LMWH are less effective in preventing uptake and degradation of LPL in the liver. Model studies in humans indicate that LMWH cause as much depletion of LPL stores and impaired lipolysis of triglyceride (TG)-rich lipoproteins as UFH does.

Methods. Two anticoagulant regimes based on present clinical practice were compared in nine HD patients. UFH was administered as a primed infusion, whereas the LMWH (dalteparin) was given only as a single bolus pre-dialysis. Blood was sampled regularly for LPL activity and TG.

Results. LPL activity in blood was significantly lower during the dialysis with dalteparin. To explore the remaining activity at the endothelium, a bolus of UFH was given after 3 h of dialysis. The bolus brought out about the same amount of LPL, regardless of whether UFH or dalteparin had been used during dialysis. The increase in TG was significantly higher during dialysis with dalteparin.

Conclusions. This study indicates that a single bolus of dalteparin pre-dialysis interferes with the LPL system as much as, or more than an infusion of UFH does.

Keywords: dalteparin; dialysis; heparin; lipoprotein lipase; low molecular weight heparins.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Clin. Chem.Home page
R. Tertti, S. Wittfooth, P. Porela, K.E. Airaksinen, K. Metsarinne, and K. Pettersson
Intravenous Administration of Low Molecular Weight and Unfractionated Heparin Elicits a Rapid Increase in Serum Pregnancy-Associated Plasma Protein A
Clin. Chem., June 1, 2009; 55(6): 1214 - 1217.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.